IP Library Assignment 065045/0560
Patent Assignment
Reel/Frame 065045/0560

Security Interest

Recorded: 2023-09-27 Pages: 10
Assignor
Assignee
JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
IL1-1145/54/63, P.O. BOX 6026, CHICAGO, ILLINOIS, 60680-6026
Covered Properties (44)
Ready-To-Use Injectable Pharmaceutical Compositions Comprising Neostigmine and Glycopyrrolate
Application: 16/170,948 →
Publication: US 2019/0374462
Ready-To-Use Injectable Pharmaceutical Compositions Comprising Neostigmine and Glycopyrrolate
Application: 16/176,866 →
Pharmaceutical Compositions of Testosterone
Application: 16/363,376 →
Publication: US 2019/0307772
Pharmaceutical Compositions of Meloxicam
Application: 16/371,293 →
Publication: US 2019/0307681
Pharmaceutical Compositions of Posaconazole
Application: 16/410,149 →
Publication: US 2020/0237753
Pharmaceutical Compositions of Lurasidone
Application: 16/697,415 →
Publication: US 2020/0222394
Liquid Pharmaceutical Compositions of Baclofen for Oral Administration
Application: 16/752,058 →
Publication: US 2020/0375932
Pharmaceutical Compositions of Lurasidone
Application: 16/774,457 →
Publication: US 2020/0222395
Pharmaceutical Compositions of Nilotinib
Application: 16/793,833 →
Publication: US 2020/0261449
Pharmaceutical Compositions of Nilotinib
Application: 16/953,728 →
Publication: US 2021/0077485
Stable Pharmaceutical Compositions of Dihydroergotamine Mesylate
Application: 17/028,863 →
Publication: US 2021/0085657
Pharmaceutical Compositions of Tofacitinib for Oral Administration
Application: 17/239,007 →
Publication: US 2021/0338677
Pharmaceutical Liquid Compositions of Meloxicam
Application: 17/368,367 →
Publication: US 2022/0008337
Ready-To-Use Injectable Pharmaceutical Compositions Comprising Neostigmine and Glycopyrrolate
Application: 17/386,139 →
Publication: US 2021/0369604
Stable Oral Suspensions of Baclofen
Application: 17/591,438 →
Publication: US 2022/0347140
Pharmaceutical Compositions of Cabozantinib
Application: 17/673,583 →
Publication: US 2022/0265633
Pharmaceutical Compositions of Testosterone
Application: 17/696,319 →
Publication: US 2022/0202830
Pharmaceutical Liquid Compositions of Meloxicam
Application: 17/725,772 →
Publication: US 2022/0249507
Stable Pharmaceutical Compositions of Succinylcholine Chloride
Application: 17/822,399 →
Publication: US 2023/0086729
Stable Pharmaceutical Compositions of Succinylcholine Chloride
Application: 17/822,756 →
Publication: US 2023/0091021
Pharmaceutical Compositions of Cabozantinib
Application: 17/824,518 →
Publication: US 2022/0280500
Pharmaceutical Compositions of Mifepristone
Application: 17/843,669 →
Publication: US 2023/0085008
Stable Pharmaceutical Compositions of Clonidine
Application: 17/866,115 →
Publication: US 2023/0149359
Pharmaceutical Compositions of Cabozantinib
Application: 17/866,877 →
Publication: US 2022/0362235
Stable Pharmaceutical Compositions of Bendamustine
Application: 17/877,476 →
Pharmaceutical Compositions of Cabozantinib
Application: 17/885,105 →
Publication: US 2022/0387418
Stable Oral Suspensions of Baclofen
Application: 17/948,882 →
Publication: US 2023/0028957
Stable Pharmaceutical Compositions of Cyclophosphamide
Application: 17/961,943 →
Publication: US 2023/0119069
Stable Liquid Compositions of Netupitant and Palonosetron
Application: 18/069,204 →
Publication: US 2023/0190737
Modified-Release Dosage Forms of Ruxolitinib
Application: 18/075,150 →
Publication: US 2023/0172863
Stable Oral Suspensions of Baclofen
Application: 18/087,625 →
Publication: US 2023/0139109
Ready-To-Use Injectable Pharmaceutical Compositions Comprising Neostigmine and Glycopyrrolate
Application: 18/098,505 →
Publication: US 2023/0149294
Pharmaceutical Compositions of Cabozantinib
Application: 18/108,423 →
Publication: US 2023/0181561
Liquid Pharmaceutical Compositions of Baclofen for Oral Administration
Application: 18/114,502 →
Publication: US 2024/0189229
Stable Pharmaceutical Compositions of Apixaban
Application: 18/117,808 →
Publication: US 2023/0285368
Stable Oral Suspensions of Baclofen
Application: 18/130,597 →
Publication: US 2023/0285341
Stable Pharmaceutical Compositions of Hydroxyurea
Application: 18/163,811 →
Publication: US 2023/0301945
Stable Liquid Compositions of Glucagon
Application: 18/202,103 →
Publication: US 2023/0381282
Pharmaceutical Compositions of Testosterone
Application: 18/299,493 →
Publication: US 2023/0248742
Pharmaceutical Compositions of Cabozantinib
Application: 18/312,857 →
Publication: US 2023/0270736
Stable Pharmaceutical Compositions of Bendamustine
Application: 18/328,392 →
Publication: US 2023/0310384
Stable Pharmaceutical Compositions of Edaravone
Application: 18/340,067 →
Publication: US 2024/0285582
Stable Pharmaceutical Compositions of Apixaban
Application: 18/357,295 →
Publication: US 2024/0050416
Pharmaceutical Compositions of Tofacitinib for Oral Administration
Application: 18/447,620 →
Publication: US 2023/0398120
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 26, 2018
From: BHISE, RAHUL DHULAJI; SINGH, AJAY KUMAR; MAHADIK, MAHADEO VASANT; DUBEWAR, ASHISH ANILRAO
To: SLAYBACK PHARMA LLC
Reel/Frame 047322/0911 →
Assignment of Assignor's Interest Oct 31, 2018
From: BHISE, RAHUL DHULAJI; SINGH, AJAY KUMAR; MAHADIK, MAHADEO VASANT; DUBEWAR, ASHISH ANILRAO
To: SLAYBACK PHARMA LLC
Reel/Frame 047373/0474 →
Assignment of Assignor's Interest Mar 25, 2019
From: SONI, UMANGI K.; SINGH, PREM PRAKASH; BAPATU, HANIMI REDDY; SUBBAPPA, PRAVEEN KUMAR
To: SLAYBACK PHARMA LLC
Reel/Frame 048688/0760 →
Assignment of Assignor's Interest Apr 11, 2019
From: BHISE, RAHUL DHULAJI; DUBEWAR, ASHISH ANILRAO; MOLUGU, PRASHANTH REDDY
To: SLAYBACK PHARMA LLC
Reel/Frame 048857/0296 →
Assignment of Assignor's Interest May 13, 2019
From: JAIN, PARAS P.; JAIN, GIRISH KUMAR
To: SLAYBACK PHARMA LLC
Reel/Frame 049157/0593 →
Assignment of Assignor's Interest Nov 27, 2019
From: JAIN, PARAS P.; SINGH, AJAY KUMAR; SUBBAPPA, PRAVEEN KUMAR; PRIYA, KEERTHI
To: SLAYBACK PHARMA LLC
Reel/Frame 051127/0293 →
Assignment of Assignor's Interest Jan 27, 2020
From: DUBE, SUSHANT OMPRAKASH; JAIN, GIRISH KUMAR; KEESARA, VENKATESHWAR REDDY; MATHEW, JOSH CHANDY
To: SLAYBACK PHARMA LLC
Reel/Frame 051629/0699 →
Assignment of Assignor's Interest Feb 20, 2020
From: JAIN, PARAS P.; SINGH, AJAY KUMAR; PRIYA, KEERTHI; JAIN, GIRISH KUMAR
To: SLAYBACK PHARMA LLC
Reel/Frame 051868/0974 →
Assignment of Assignor's Interest Jan 26, 2022
From: CHINNARI, HARISH GOVINDARAJA SETTY; BATTINI, SOMASHEKHAR; LOHAR, JAGDISH LOTAN
To: SLAYBACK PHARMA LLC
Reel/Frame 058777/0235 →
Assignment of Assignor's Interest Jan 26, 2022
From: DUBEWAR, ASHISH ANILRAO; PILLAI, SUMITRA ASHOKKUMAR; KARE, PRADEEP KUMAR; UMMITI, KUMAR SWAMY
To: SLAYBACK PHARMA LLC
Reel/Frame 058778/0874 →
Assignment of Assignor's Interest Feb 10, 2022
From: DUBE, SUSHANT OMPRAKASH; PATTEWAR, PURUSHOTTAM SAKHAHARI; CHATKI, PANKAJ KISAN; PILLAI, SUMITRA ASHOKKUMAR
To: SLAYBACK PHARMA LLC
Reel/Frame 059004/0848 →
Assignment of Assignor's Interest Feb 16, 2022
From: DUBE, SUSHANT OMPRAKASH; KULKARNI, PURUSHOTTAM DATTATRAYA; PATTEWAR, PURUSHOTTAM SAKHAHARI; PILLAI, SUMITRA ASHOKKUMAR
To: SLAYBACK PHARMA LLC
Reel/Frame 059025/0876 →
Assignment of Assignor's Interest Mar 3, 2022
From: DUBE, SUSHANT OMPRAKASH; SAOJI, SUPRIT DILIP; CHATKI, PANKAJ KISAN; PILLAI, SUMITRA ASHOKKUMAR
To: SLAYBACK PHARMA LLC
Reel/Frame 059156/0055 →
Assignment of Assignor's Interest Jun 6, 2023
From: MANDGE, SHAILENDRA; GUNDA, HARISH; KETHA, NAGA VENKATA DURGA PRASAD; KEESARA, VENKATESHWAR REDDY
To: SLAYBACK PHARMA LLC
Reel/Frame 063871/0167 →
Corrective Assignment to Correct the Assignment Document (Title) Previously Recorded on Reel 048688 Frame 0760. Assignor(S) Hereby Confirms the Assignment. Jun 13, 2023
From: SONI, UMANGI K.; SINGH, PREM PRAKASH; BAPATU, HANIMI REDDY; SUBBAPPA, PRAVEEN KUMAR
To: SLAYBACK PHARMA LLC
Reel/Frame 063988/0435 →
Assignment of Assignor's Interest Aug 16, 2023
From: SLAYBACK PHARMA LIMITED LIABILITY COMPANY
To: ANI PHARMACEUTICALS, INC.
Reel/Frame 064605/0274 →
Partial Termination and Release of Security Interest in Patents Apr 3, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 066987/0120 →
Assignment of Assignor's Interest Apr 19, 2024
From: SLAYBACK PHARMA LIMITED LIABILITY COMPANY
To: HIKMA PHARMACEUTICALS USA INC.
Reel/Frame 067168/0238 →
Security Interest Aug 14, 2024
From: ANI PHARMACEUTICALS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 068277/0134 →
Release of Security Interest Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →
Confirmatory Grant of Security Interest in United States Patents Mar 17, 2025
From: ARBOR PHARMACEUTICALS, LLC; AZURITY PHARMACEUTICALS, INC.; AZURITY PHARMACEUTICALS IRELAND LIMITED; SILVERGATE PHARMACEUTICALS, INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 070531/0487 →
Assignment of Assignor's Interest Apr 18, 2025
From: SLAYBACK PHARMA LIMITED LIABILITY COMPANY
To: AZURITY PHARMACEUTICALS, INC.
Reel/Frame 070877/0696 →